<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="157993">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01805193</url>
  </required_header>
  <id_info>
    <org_study_id>12/SS/0078</org_study_id>
    <nct_id>NCT01805193</nct_id>
  </id_info>
  <brief_title>Myocardial Blood Flow by 15O Water PET</brief_title>
  <official_title>Validation of Computed Tomography Myocardial Perfusion Imaging Using Quantification of Myocardial Blood Flow by Positron Emission Tomography With 15O-water</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Edinburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Edinburgh</source>
  <oversight_info>
    <authority>United Kingdom: Research Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Coronary heart disease is a very common condition caused by narrowings in the blood vessel
      supplying the heart. the investigators are studying new tests to diagnose heart disease. In
      this study the investigators plan to investigate a special scan called a PET/CT (Positron
      emission tomography/computed tomography) and a new type of CT (Computed tomography) scan to
      tell us about the flow of blood to the heart muscle.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will undergo PET/CT with oxygen-15 labelled water and computed tomography
      myocardial perfusion imaging.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <primary_completion_date type="Anticipated">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Myocardial blood flow</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Myocardial blood flow ( ml/g/min) measured by oxygen-15 water positron emission tomography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fractional flow reserve</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Fractional flow reserve measured during invasive coronary angiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial perfusion</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Myocardial perfusion measured as hypoperfusion on adenosine computed tomography myocardial perfusion imaging</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Coronary Heart Disease</condition>
  <arm_group>
    <arm_group_label>Suspected coronary heart disease</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Computed tomography myocardial perfusion imaging</intervention_name>
    <arm_group_label>Suspected coronary heart disease</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oxygen 15 labelled water positron emission tomography</intervention_name>
    <arm_group_label>Suspected coronary heart disease</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Outpatients with suspected coronary heart disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  suspected coronary artery disease

        Exclusion Criteria:

          -  inability or unwillingness to undergo CT or PET imaging

          -  renal failure (serum creatinine &gt;200 um/L or eGFR &lt;30 ml/min)

          -  hepatic failure

          -  allergy to iodinated contrast

          -  pregnancy

          -  contraindication to adenosine

          -  inability to give informed consent

          -  atrial fibrillation with a fast ventricular rate (&gt;70 beats per minute)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Newby, PhD DM</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Edinburgh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michelle Williams, MBChB</last_name>
    <email>michelle.williams@ed.ac.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinical Research Imaging Centre</name>
      <address>
        <city>Edinburgh</city>
        <state>Scotland</state>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Williams, MBCHb</last_name>
      <email>michelle.williams@ed.ac.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 4, 2013</lastchanged_date>
  <firstreceived_date>February 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronary heart disease</keyword>
  <keyword>computed tomography myocardial perfusion</keyword>
  <keyword>positron emission tomography</keyword>
  <keyword>oxygen 15 labelled water</keyword>
  <keyword>myocardial perfusion</keyword>
  <keyword>myocardial blood flow</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
